SSRI: Clinical Trials

10 trials of SSRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 recruiting, 1 terminated, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1

Follow SSRI: new trials by email Literature Review of SSRI trials Research Report on SSRI

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
Virtual Reality Exposure Therapy, Sertraline (Oral Antidepressant) - Social Anxiety Disorder
Phase 4RecruitingEmine Kanmaz562024-11-152025-09-25
Detoxification From the Lipid Tract
electroencephalogram biofeedback, electrical brain stimulation, ultra-low frequency transcranial magnetic stimulation - COVID-19 Vaccine Adverse Reaction
Phase 4CompletedPachankis, Yang I., M.D.12024-02-262024-04-10
Non-invasive BCI and Application Verification for Depressed People
SSRI, rTMS, Neuro-Feedback - Depression, Major Depressive Disorder
Phase 4RecruitingShanghai Mental Health Center4002023-07-012024-05-16
A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women
Sertraline, Interpersonal therapy - Perinatal Depression, HIV-1-infection
Phase 4CompletedUniversity of North Carolina, Chapel Hill802019-10-302021-11-10
The ISLAND Study: InSuLa Assessed Needs for Depression
Selective serotonin re-uptake inhibitor, Cognitive Behavioral Therapy, Combination treatment (SSRI + CBT) - Depression
Phase 4CompletedEmory University772014-09-012020-11-05
Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
Sertraline, Cognitive Behavioural Therapy - Generalised Anxiety Disorder
Phase 4TerminatedUniversity College, London52014-08-012016-07-11
Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
SSRI, CBT - Internalizing Psychopathologies (IPs) Depression and Anxiety
Phase 4CompletedUniversity of Illinois at Chicago2712013-12-132018-10-11
The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
SSRI monotherapy, Seroquel XR adjunctive - Major Depressive Disorder
Phase 4UnknownInje University602011-05-012012-11-01
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
Effexor, SSRI - Major Depressive Disorder
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer11512007-04-012012-03-05
Escitalopram Treatment In Acute Stroke
Escitalopram, Placebo - Stroke
Phase 4WithdrawnUniversity of Aarhus2012-06-19

Conditions studied

Depression (4)  ·  Depressive Disorder, Major (4)  ·  Anxiety Disorders (2)  ·  Bipolar Disorder (1)  ·  Generalized Anxiety Disorder (1)  ·  Ichthyosis prematurity syndrome (1)  ·  Phobia, Social (1)  ·  Stroke (1)

Sponsors

Emine Kanmaz (1)  ·  Emory University (1)  ·  Inje University (1)  ·  Pachankis, Yang I., M.D. (1)  ·  Shanghai Mental Health Center (1)  ·  University College, London (1)  ·  University of Aarhus (1)  ·  University of Illinois at Chicago (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

China (3)  ·  United States (2)  ·  Denmark (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  Zambia (1)

Top investigators

Boadie W Dunlop, MD/MS (1)  ·  Elizabeth Stringer, MD (1)  ·  Grethe Andersen, Prof. DMSc (1)  ·  K. Luan Phan, MD (1)  ·  Marta Buszewicz (1)  ·  Seung-Hwan Lee, MD, PhD (1)  ·  Zhenghui Yi, chief physician (1)

Results publications

PMID 29894598, PMID 31060042, PMID 33896622, PMID 34274600, PMID 35803896, PMID 42286600

NIH funding

R01MH073719 (1), R01MH101497 (1), R21MH115806 (1)